Sat, 28 May 2022

Generic Drugs Market

Market Overview:

According to the latest report by IMARC Group, titled "Generic Drugs Market Size: Global Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026", the global generic drugs market reached a value of US$ 386 Billion in 2020. Looking forward, IMARC Group expects the market to exhibit moderate growth during 2021-2026. A generic drug is an off-patented drug that is identical to other branded medicines in terms of effect, form, dosage, intended use, quality, and safety. These drugs can be manufactured only after the patent expiration of the brand-name drug. As compared to other branded drugs, these are less expensive and do not require extensive research and testing.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Sample Report:

Market Trends and Drivers:

The global market is primarily driven by the rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, Alzheimer's disease, and Parkinson's disease. Furthermore, the significant growth in the pharmaceutical industry has driven market growth across the globe. Apart from this, the rising expenditure by the government as well as private companies to manufacture generic drugs that can improve the healthcare system has created a positive outlook for the market. Moreover, the growth in the geriatric population has positively influenced the market growth. Additionally, the upcoming patent expiry of many brand-name drugs is expected to drive the market towards growth.

Explore Full Report with TOC & List of Figure:

Competitive Landscape:

By IMARC group the global generic drugs market report has also analyzed the competitive landscape of the market with some of the top generic drug manufacturing companies being

Some of these key players include:

  • Teva Pharmaceuticals Industries Ltd.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Fresenius SE & Co.
  • Lupin Limited
  • Endo Pharmaceuticals Inc.
  • Aurobindo Pharma Limited
  • Aspen Pharmacare Holdings Limited

Key Market Segmentation:

Breakup by Therapy Area:

  • Central Nervous System
  • Cardiovascular
  • Dermatology
  • Genitourinary/Hormonal
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Others

Breakup by Drug Delivery:

  • Oral
  • Injectables
  • Dermal/Topical
  • Inhalers

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the Report:

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • COVID-19 Impact on the Market
  • Porter's Five Forces Analysis
  • Historical, Current and Future Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Structure of the Market
  • Value Chain Analysis
  • Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Other Latest Research Reports By IMARC Group:

Green Cement Market Research Report:

Smart TV Market Research Report:

Rare Earth Elements Market Research Report:

Hand Sanitizer Market Research Report:

Sports Nutrition Market Research Report:

Packaging Machinery Market Research Report:

Luxury Furniture Market Research Report:

Personal Protective Equipment Market Research Report:

Pre-Engineered Building Market Research Report:

Caustic Soda Market Research Report:

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Tags: , , , , ,

See Campaign: Information:IMARC Group

30 N Gould St, Ste R

Sheridan, WY (Wyoming) 82801 USA


Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800Tags:Menafn, IPS, Reportedtimes, PR-Wirein, iCN Internal Distribution, Research Newswire, English

Sign up for Miami News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!